Maggot Debridement Therapy: A Suitable Treatment Option for Chronic Wound Care - Issuu

Chronic, non-healing wounds due to burns, diabetes, and other injuries cost United States patients about 50 billion dollars each year. Traditionally, treatment has involved surgical debridement of necrotic tissue and frequent cleaning and changing of the wound and dressings to manage infection risk and promote healing. In the 1920s, a new method of wound debridement called maggot debridement therapy or MDT emerged and has continually developed into an effective treatment strategy. Sterile, live blow fly larvae are either placed into the wound and sealed in by gauze or held in place by a mesh bag in the wound. Secretions of the larvae kill bacteria, dissolve necrotic tissue, and stimulate healthy tissue formation. Studies have shown that MDT has the power to debride and contribute to wound healing as early as four weeks, compared to conventional therapy. With multiple benefits and few side-effects, MDT is a well-supported and increasingly accessible tool for physicians in chronic-wound treatments.

The principles of maggot therapy and its role in contemporary wound care

Debridement and wound healing using larval therapy.

PDF) The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients

Figure 3 from A retrospective, quality improvement review of maggot debridement therapy outcomes in a foot and leg ulcer clinic.

Fig. Patient's foot ulcer before and after the maggot therapy. (A).

Wound Masterclass - December 2023 by woundmasterclass - Issuu

A novel mechanism in maggot debridement therapy: protease in excretion/secretion promotes hepatocyte growth factor production

Maggot debridement therapy for an electrical burn injury with instructions for the use of Lucilia sericata larvae

Wound Aetiologies, Patient Characteristics, and Healthcare Settings Amenable to Maggot Therapy by woundmasterclass - Issuu

Diabetes Wound Care (Maggot Debridement Therapy)

Efficacy of Maggot Debridement Therapy on Refractory Atypical Diabetic Foot Ulcers: An Open-Label Study